Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $9.4115, but opened at $8.49. Aspen Pharmacare shares last traded at $8.49, with a volume of 1,010 shares changing hands.
Aspen Pharmacare Price Performance
The company has a debt-to-equity ratio of 0.36, a quick ratio of 2.66 and a current ratio of 3.64. The business’s 50-day moving average price is $9.08 and its two-hundred day moving average price is $8.56.
Aspen Pharmacare Company Profile
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Featured Articles
- Five stocks we like better than Aspen Pharmacare
- Lilly’s Merida Deal Shows the GLP-1 King Is Already Thinking Beyond Obesity
- From High Dividend Growth to High Yield, These 3 Stocks Just Boosted Dividend Payouts
- The Pentagon’s Grok Rollout Puts These 3 Stocks in Focus
- Copper Surges as Shifting Trade Policy and AI Demand Collide
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
